OssDsign Future Growth
Future criteria checks 2/6
OssDsign is forecast to grow earnings and revenue by 56.2% and 23.9% per annum respectively. EPS is expected to grow by 59% per annum. Return on equity is forecast to be -20.5% in 3 years.
Key information
56.2%
Earnings growth rate
59.0%
EPS growth rate
| Medical Equipment earnings growth | 16.2% |
| Revenue growth rate | 23.9% |
| Future return on equity | -20.5% |
| Analyst coverage | Low |
| Last updated | 10 Sep 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 217 | -24 | -28 | -27 | 3 |
| 12/31/2025 | 169 | -42 | -42 | -42 | 4 |
| 12/31/2024 | 124 | -56 | -75 | -75 | 4 |
| 6/30/2024 | 123 | -114 | -91 | -91 | N/A |
| 3/31/2024 | 118 | -118 | -95 | -95 | N/A |
| 12/31/2023 | 112 | -130 | -94 | -94 | N/A |
| 9/30/2023 | 97 | -109 | -93 | -93 | N/A |
| 6/30/2023 | 83 | -95 | -93 | -93 | N/A |
| 3/31/2023 | 71 | -99 | -92 | -92 | N/A |
| 12/31/2022 | 57 | -99 | -86 | -86 | N/A |
| 9/30/2022 | 46 | -96 | -82 | -82 | N/A |
| 6/30/2022 | 38 | -93 | -98 | -98 | N/A |
| 3/31/2022 | 33 | -95 | -90 | -90 | N/A |
| 12/31/2021 | 32 | -94 | -90 | -90 | N/A |
| 9/30/2021 | 29 | -90 | -94 | -93 | N/A |
| 6/30/2021 | 27 | -92 | -77 | -76 | N/A |
| 3/31/2021 | 23 | -90 | -83 | -80 | N/A |
| 12/31/2020 | 25 | -85 | -82 | -79 | N/A |
| 9/30/2020 | 24 | -89 | -81 | -79 | N/A |
| 6/30/2020 | 22 | -89 | -90 | -88 | N/A |
| 3/31/2020 | 22 | -85 | -87 | -86 | N/A |
| 12/31/2019 | 18 | -84 | -87 | -87 | N/A |
| 9/30/2019 | 18 | -72 | -92 | -90 | N/A |
| 6/30/2019 | 20 | -66 | -79 | -75 | N/A |
| 3/31/2019 | 21 | -62 | -83 | -78 | N/A |
| 12/31/2018 | 21 | -56 | -74 | -66 | N/A |
| 12/31/2017 | 16 | -63 | N/A | -41 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 5J6 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 5J6 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 5J6 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 5J6's revenue (23.9% per year) is forecast to grow faster than the German market (5.5% per year).
High Growth Revenue: 5J6's revenue (23.9% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 5J6 is forecast to be unprofitable in 3 years.